Cargando…

Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease

Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Czub, Paweł, Cacko, Andrzej, Gawałko, Monika, Tataj, Emanuel, Poliński, Jakub, Pawlik, Kacper, Cichoń, Romuald, Hendzel, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320047/
https://www.ncbi.nlm.nih.gov/pubmed/30558022
http://dx.doi.org/10.1097/MD.0000000000013572
_version_ 1783385158430228480
author Czub, Paweł
Cacko, Andrzej
Gawałko, Monika
Tataj, Emanuel
Poliński, Jakub
Pawlik, Kacper
Cichoń, Romuald
Hendzel, Piotr
author_facet Czub, Paweł
Cacko, Andrzej
Gawałko, Monika
Tataj, Emanuel
Poliński, Jakub
Pawlik, Kacper
Cichoń, Romuald
Hendzel, Piotr
author_sort Czub, Paweł
collection PubMed
description Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical approaches. The aim of the study was to assess the effectiveness of the ESL and the ESII risk scores in predicting in-hospital death and prolonged hospitalization in intensive care unit (ICU) after coronary artery bypass grafting (CABG), aortic valve replacement (AVR), and mitral valve replacement (MVR) by comparison of an estimated risk and a real-life observation at a reference cardiac surgery unit. This retrospective study was based on medical records of patients who underwent a CABG, AVR, or MVR at a reference cardiac surgery unit in a 2-year period. Primary endpoint was defined as in-hospital death. Secondary endpoint was a prolonged hospitalization at the ICU, defined as longer than 3 days. The study encompassed 586 patients [114 (23.1%) female, mean age 65.8 ± 10.5 years], including 493 patients undergoing CABG, 66 patients undergoing AVR, and 27 patients undergoing MVR. The ESL and ESII risk scores were higher in MVR subgroup (31.7% ± 30.5% and 15.3% ± 19.4%) and AVR subgroup (9.7% ± 11.6% and 3.2% ± 4.2%) than in CABG subgroup (6.9% ± 10.4% and 2.5% ± 4.1%; P < .001). Subgroups of patients were significantly different in terms of clinical, biochemical, and echocardiography factors. Primary endpoint occurred in 36 (6.1%) patients: 21 (4.3%), 7 (10.6%), and 8 (29.7%) in CABG, AVR, and MVR subgroups, respectively. The ESII underestimated the risk of mortality. Secondary endpoint occurred in 210 (35.8%) patients: 172 (34.9%), 22 (33.4%), and 16 (59.3%) in CABG, AVR, and MVR subgroups, respectively. In the study, the perioperative risk estimated with the ESL and the ESII risk scores was compared with a real-life outcome among over 500 patients. Regardless of the type of surgery, result in the ESL was better correlated with the risk of in-hospital death.
format Online
Article
Text
id pubmed-6320047
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63200472019-01-24 Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease Czub, Paweł Cacko, Andrzej Gawałko, Monika Tataj, Emanuel Poliński, Jakub Pawlik, Kacper Cichoń, Romuald Hendzel, Piotr Medicine (Baltimore) Research Article Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical approaches. The aim of the study was to assess the effectiveness of the ESL and the ESII risk scores in predicting in-hospital death and prolonged hospitalization in intensive care unit (ICU) after coronary artery bypass grafting (CABG), aortic valve replacement (AVR), and mitral valve replacement (MVR) by comparison of an estimated risk and a real-life observation at a reference cardiac surgery unit. This retrospective study was based on medical records of patients who underwent a CABG, AVR, or MVR at a reference cardiac surgery unit in a 2-year period. Primary endpoint was defined as in-hospital death. Secondary endpoint was a prolonged hospitalization at the ICU, defined as longer than 3 days. The study encompassed 586 patients [114 (23.1%) female, mean age 65.8 ± 10.5 years], including 493 patients undergoing CABG, 66 patients undergoing AVR, and 27 patients undergoing MVR. The ESL and ESII risk scores were higher in MVR subgroup (31.7% ± 30.5% and 15.3% ± 19.4%) and AVR subgroup (9.7% ± 11.6% and 3.2% ± 4.2%) than in CABG subgroup (6.9% ± 10.4% and 2.5% ± 4.1%; P < .001). Subgroups of patients were significantly different in terms of clinical, biochemical, and echocardiography factors. Primary endpoint occurred in 36 (6.1%) patients: 21 (4.3%), 7 (10.6%), and 8 (29.7%) in CABG, AVR, and MVR subgroups, respectively. The ESII underestimated the risk of mortality. Secondary endpoint occurred in 210 (35.8%) patients: 172 (34.9%), 22 (33.4%), and 16 (59.3%) in CABG, AVR, and MVR subgroups, respectively. In the study, the perioperative risk estimated with the ESL and the ESII risk scores was compared with a real-life outcome among over 500 patients. Regardless of the type of surgery, result in the ESL was better correlated with the risk of in-hospital death. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320047/ /pubmed/30558022 http://dx.doi.org/10.1097/MD.0000000000013572 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Czub, Paweł
Cacko, Andrzej
Gawałko, Monika
Tataj, Emanuel
Poliński, Jakub
Pawlik, Kacper
Cichoń, Romuald
Hendzel, Piotr
Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title_full Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title_fullStr Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title_full_unstemmed Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title_short Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
title_sort perioperative risk assessment with euroscore and euroscore ii in patients with coronary artery or valvular disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320047/
https://www.ncbi.nlm.nih.gov/pubmed/30558022
http://dx.doi.org/10.1097/MD.0000000000013572
work_keys_str_mv AT czubpaweł perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT cackoandrzej perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT gawałkomonika perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT tatajemanuel perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT polinskijakub perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT pawlikkacper perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT cichonromuald perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease
AT hendzelpiotr perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease